Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

Author:

Flaherty Kevin R.1,Wells Athol U.1,Cottin Vincent1,Devaraj Anand1,Walsh Simon L.F.1,Inoue Yoshikazu1ORCID,Richeldi Luca1,Kolb Martin1,Tetzlaff Kay1,Stowasser Susanne1,Coeck Carl1,Clerisme-Beaty Emmanuelle1,Rosenstock Bernd1,Quaresma Manuel1,Haeufel Thomas1,Goeldner Rainer-Georg1,Schlenker-Herceg Rozsa1,Brown Kevin K.1

Affiliation:

1. From the Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor (K.R.F.); the National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust (A.U.W.), the National Heart and Lung Institute, Imperial College (A.U.W., A.D., S.L.F.W.), and the Department of Radiology, Royal Brompton and Harefield NHS Foundation Trust (A.D.) — all in London; the National Reference Center for Rare Pulmonary Diseases, Louis Pradel...

Funder

Boehringer Ingelheim

Publisher

Massachusetts Medical Society

Subject

General Medicine

Cited by 1527 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3